Biotech · Private company
Aileron Therapeutics, Inc.
Track this companyFree. Adds Aileron Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- ALRN-6924Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ALRN-6924Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- ALRN-6924Phase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ALRN-6924Phase 1 · Prevention of Chemotherapy-induced MyelosuppressionClinicalTrials.gov · fetched Nov 12, 2026
- ALRN-6924 in combination with cytarabinePhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)Phase 1 · Prevention of Chemotherapy-induced MyelosuppressionClinicalTrials.gov · fetched Nov 12, 2026
- TopotecanPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast CancerPHASE1 · TERMINATED · started Jan 9, 2023ClinicalTrials.gov NCT05622058 · fetched Nov 12, 2026
- A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)PHASE1 · TERMINATED · started Sep 3, 2019ClinicalTrials.gov NCT04022876 · fetched Nov 12, 2026
- Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric CancerPHASE1 · COMPLETED · started Nov 1, 2018ClinicalTrials.gov NCT03654716 · fetched Nov 12, 2026
- Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic SyndromePHASE1 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02909972 · fetched Nov 12, 2026
- ALRN-6924 in Patients With Advanced Solid Tumors or LymphomasPHASE1_PHASE2 · COMPLETED · started Oct 1, 2014ClinicalTrials.gov NCT02264613 · fetched Nov 12, 2026